Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7462 p89-94
28 July 2007

This section
Reprint   Photocopy

PDF 180K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 89   90   91   92   93   94 

89 Pharmacists' role in reducing MRSA highlighted Meticillin-resistant Staphyloccus aureus infections have fallen for the third quarter in succession, as pharmacists' role in infection control is highlighted by the Healthcare Commission
PJ 2007;279:89
Full Text

89 Government proposes devolving global sum to primary care trusts Proposals to change legislation governing community pharmacy funding in England, which include devolving the global sum to primary care trusts, were announced by the Department of Health this week
PJ 2007;279:89
Full Text

89 Napp decides to deal only with three selected wholesalers Another pharmaceutical manufacturer — Napp Pharmaceuticals — has decided to deal only with selected wholesalers
PJ 2007;279:89
Full Text



90 Antibiotic prescribing guidance still ignored by GPs GPs are still prescribing antibiotics in over 40 per cent of cases of upper respiratory tract infections, and in over 60 per cent of cases of sore throat, otitis media and sinusitis, according to an analysis of the UK's General Practice Research Database. Such prescribing does not comply with national guidelines
PJ 2007;279:90
Full Text

90 Chlamydia continues to rise Chlamydia diagnoses continue to increase, new figures from the Health Protection Agency reveal
PJ 2007;279:90
Full Text

90 Hospitals struggle to cope with flood effects Hospitals in parts of England that remain under water after torrential rain last week are cutting back on services as they find it hard to cope with the knock-on effects of flooding
PJ 2007;279:90
Full Text

90 STI care standards published Draft standards for sexual health services in Scotland were published last week
PJ 2007;279:90
Full Text

90 CPP chairman passes on chain of office after three years Charles Butler has stepped down after a three-year term as chairman of the College of Pharmacy Practice
PJ 2007;279:90
Full Text



91 Offer methadone or buprenorphine first line for opioid detoxification Methadone or buprenorphine must be offered as first-line treatment for opioid detoxification, which should be an option for opioid-dependent drug misusers who want to quit, according to National Institute for Health and Clinical Excellence guidance on substance misuse
PJ 2007;279:91
Full Text

91 Experts back methadone but say services need improving Methadone should remain the main treatment for opiate dependency in Scotland but improvements are needed in terms of the quality and consistency of services. This is the conclusion of a report from the Scottish Advisory Committee on Drug Misuse
PJ 2007;279:91
Full Text

91 BMJ study on adolescent depression contradicts NICE advice A study on adolescent depression published in the BMJ contradicts National Institute for Health and Clinical Excellence (NICE) guidelines
PJ 2007;279:91
Full Text

91 Bradshaw takes responsibility for professional regulation Ben Bradshaw, Minister of State for Health Services, has been given responsibility for the regulation of health professionals and will steer the forthcoming Health and Social Care Bill through the next session of Parliament
PJ 2007;279:91
Full Text



92 Prescription charge consultation to start in autumn Proposals on changes to the prescription charge system in England are to be announced in the autumn by the Department of Health
PJ 2007;279:92
Full Text

92 Practice-based commissioning warning Community pharmacists' profits could be negatively affected if they fail to get involved with practice-based commissioning, according to guidance launched this week by the Royal Pharmaceutical Society
PJ 2007;279:92
Full Text

92 OFT still pressing for control-of-entry rules to be scrapped Pressure is being maintained on the Department of Health by the Office of Fair Trading to remove remaining restrictions over granting new NHS pharmacy contracts
PJ 2007;279:92
Full Text

92 Final transitional payment announced for Scotland Pharmacy contractors in Scotland will be paid a share of a £1.627m final transitional reimbursement payment (TRP) in September, it was announced last week
PJ 2007;279:92
Full Text



93 Rimonabant's depression warnings to be upgraded Rimonabant (Acomplia) should not be prescribed for patients who have major depression or who are being treated with antidepressants because of the risk of exacerbating psychiatric problems, the European Medicines Agency (EMEA) has recommended
PJ 2007;279:93
Full Text

93 Guidance on LPS contracts for low-volume pharmacies expected Guidance on developing local pharmaceutical services (LPS) contracts to support low-volume pharmacies is expected to be ready by September, the Pharmaceutical Services Negotiating Committee has revealed
PJ 2007;279:93
Full Text

93 NHS should promote pharmacy as alternative to GP services Most patients are satisfied with access to GP services in England, according to the results of a survey commissioned by the Department of Health. However, 16 per cent of the 2.2 million respondents were not happy with their GPs' opening times, nearly half of whom would like practices to open on Saturdays and a quarter on a weekday evening
PJ 2007;279:93
Full Text

93 De Montfort remains on probation as MPharm provider De Montfort University remains on probation as an MPharm provider following a visit from the Royal Pharmaceutical Society last month
PJ 2007;279:93
Full Text

93 Developments in medicines management must speed up Developments in medicines management are heading in the right direction, but need to speed up, according to David Webb, principal pharmaceutical officer, Department of Health
PJ 2007;279:93
Full Text



94 Divergent views emerge over status of loperamide Differences of opinion between the Royal Pharmaceutical Society and the National Pharmacy Association have emerged over a proposal to add the treatment of acute diarrhoea associated with previously diagnosed irritable bowel syndrome (IBS) to the general sale list indications for the loperamide products Imodium capsules and Imodium Instants
PJ 2007;279:94
Full Text

94 OTC abuse put under Parliamentary scrutiny There is to be a Parliamentary inquiry into the scale and nature of the misuse of over-the-counter and prescription medicines
PJ 2007;279:94
Full Text

94 Warning over metabolites causing glucose meters to misread Home glucose meters may overestimate blood sugar levels of patients undergoing peritoneal dialysis or receiving immunoglobulin preparations, the Medicines and Healthcare products Regulatory Agency has warned
PJ 2007;279:94
Full Text

94 US-style methylamphetamine awareness scheme planned Pharmacy staff will soon be offered a modified training programme that originates from the US to raise awareness of the risk of pseudoephedrine- and ephedrine-containing products being used to make illegal methylamphetamine. The programme will meet a specification agreed by a range of pharmacy bodies
PJ 2007;279:94
Full Text

Back to Top


©The Pharmaceutical Journal